Related Experiment Video
Updated: Dec 29, 2025

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
Published on: February 16, 2024
Endoscopist's Judgment Is as Useful as Risk Scores for Predicting Outcome in Peptic Ulcer Bleeding: A Multicenter
Enric Brullet1,2,3, Pilar Garcia-Iglesias1,2,3, Xavier Calvet1,2,3
1Hospital de Sabadell, Corporació Sanitària Universitària Parc Taulí, 08208 Sabadell, Spain.
Insights
Endoscopist judgment in peptic ulcer bleeding (PUB) showed accuracy similar or superior to current risk scores for predicting rebleeding and mortality. More precise prognostic scales are needed for better patient risk stratification.
Area of Science:
- Gastroenterology
- Clinical Medicine
- Medical Diagnostics
Background:
- Guidelines advocate prognostic scales for risk stratification in non-variceal upper gastrointestinal bleeding.
- The comparative accuracy of risk scores versus clinical judgment remains uncertain.
- Peptic ulcer bleeding (PUB) management benefits from accurate risk assessment.
Purpose of the Study:
- To compare the diagnostic accuracy of endoscopist judgment against established risk scores (Rockall, Glasgow-Blatchford, Baylor, Cedars-Sinai) for predicting outcomes in peptic ulcer bleeding.
- To evaluate the predictive performance for rebleeding and mortality.
- To assess the utility of current risk stratification tools in PUB management.
Main Methods:
- Prospective study of 401 patients with peptic ulcer bleeding (PUB) from February 2006 to April 2010.
- Endoscopist's subjective risk assessment for rebleeding and mortality recorded immediately post-endoscopy.
- Independent calculation of Rockall, Glasgow-Blatchford, Baylor, and Cedars-Sinai scores.
- Analysis using receiver-operating-characteristics (ROC) curves, sensitivity, specificity, and predictive values.
Main Results:
- Endoscopist's clinical judgment demonstrated areas under the ROC curve for rebleeding (0.67-0.75) and mortality (0.84-0.9).
- These values were comparable or superior to those of the studied risk scores.
- The findings held true for both the entire patient cohort and those undergoing endoscopic therapy.
Conclusions:
- Current risk scores for predicting rebleeding and mortality in peptic ulcer bleeding patients have moderate accuracy.
- Endoscopist's clinical judgment was not outperformed by existing risk scoring systems.
- Development of more precise prognostic scales is necessary for improved risk stratification in PUB.
Abstract:
Background: Guidelines recommend using prognostic scales for risk stratification in patients with non-variceal upper gastrointestinal bleeding. It remains unclear whether risk scores offer greater accuracy than clinical evaluation. Objective: Compare the diagnostic accuracy of the endoscopist's judgment against different risk-scoring systems (Rockall, Glasgow-Blatchford, Baylor and the Cedars-Sinai scores) for predicting outcomes in peptic ulcer bleeding (PUB). Methods: Between February 2006 and April 2010 we prospectively recruited 401 patients with peptic ulcer bleeding; 225 received endoscopic treatment. The endoscopist recorded his/her subjective assessment ("endoscopist judgment") of the risk of rebleeding and death immediately after endoscopy for each patient. Independent evaluators calculated the different scores. Area under the receiver-operating-characteristics (ROC) curve, sensitivity, specificity, positive and negative predictive values were calculated for rebleeding and mortality. Results: The areas under ROC curve of the endoscopist's clinical judgment for rebleeding (0.67-0.75) and mortality (0.84-0.9) were similar or even superior to the different risk scores in both the whole group and in patients receiving endoscopic therapy. Conclusions: The accuracy of the currently available risk scores for predicting rebleeding and mortality in PUB patients was moderate and not superior to the endoscopist's judgment. More precise prognostic scales are needed.
More Related Videos
15:49Flexible Colonoscopy in Mice to Evaluate the Severity of Colitis and Colorectal Tumors Using a Validated Endoscopic Scoring System
Published on: October 16, 2013
05:50Author Spotlight: Point-of-Care Ultrasound for Gastric Content Assessment and Risk Stratification in Perioperative Care
Published on: September 22, 2023
Related Concept Videos
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical Interventions for Peptic Ulcer Disease
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...